RT Journal
T1 MUltistate fungal meningitis outbreak— interim guidance for treatment
JF JAMA
JO JAMA
YR 2012
FD November 28
VO 308
IS 20
SP 2074
OP 2074
DO 10.1001/jama.2012.64953
UL http://dx.doi.org/10.1001/jama.2012.64953
AB 
CDC and the Food and Drug Administration (FDA) continue to work closely with state and local public health departments on the multistate meningitis outbreak investigation of fungal infections among patients who received a steroid injection of a potentially contaminated product into the spinal area. The investigation also includes possible fungal infections associated with injections in a peripheral joint space. These cases are associated with a potentially contaminated steroid medication prepared by New England Compounding Center (NECC) in Framingham, Massachusetts.